From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
April 4, 2016
Philadelphia, PA, April 4, 2016 – IntegriChain, a rapidly growing cloud software company focused on channel management for life sciences suppliers, today announced a major enhancement to IntegriChain Scorecard, the industry’s first fully automated and configurable end-to-end platform for distribution agreement management, improving the profitability and quality of national account relationships. This platform now includes Scorecard Analytics, combining Scorecard data with robust data analysis and visualization capabilities. The enhancement allows Scorecard users to utilize their robust Scorecard data to further maximize pay-for-performance by analyzing channel investment against performance through IntegriChain’s powerful query and reporting tools.
“With the incredible amount of investment in the life sciences channel to assure patient access to critical medications, it is essential that trade partners maintain the highest levels of service to complete the patient access,” said Sunay Shah, Executive Director of Product Management at IntegriChain. “Scorecard Analytics unlocks the power of Scorecard data – illustrating the state of channel performance through powerful visualization tools – to identify trends that impact patient access and satisfaction to drive business decision-making.”
Scorecard Analytics utilize IntegriChain Demand Visibility and Builder to uncover meaningful business insights, create dashboards, and develop actionable visualizations using Scorecard data. With Scorecard Analytics, life sciences manufacturers can create insightful visualizations to:
IntegriChain Scorecard IntegriChain Scorecard allows life sciences manufacturers to automate the contract and payment processing associated with complex pharmaceutical distribution services contracts. Scorecard is highly configurable and auditable and supports most industry standard metrics out of the box. Additionally, Scorecard leverages the channel datasets and analytics within the core IntegriChain Cloud platform to increase Trade and Channel Operations business user efficiencies, reduce mistakes caused by poor data quality and manual processes, foster proactive trade partner communications, and mitigate compliance and financial risks associated with price speculation, diversion and poor demand visibility.
About IntegriChain IntegriChain is the leading channel management cloud used by life sciences suppliers, including nine of the top-10 pharmaceutical manufacturers, to drive channel collaboration and to improve the efficiency of how products reach customers. Pharmaceutical, biopharm/specialty pharma, generics, and consumer health suppliers use IntegriChain to manage their supply chain relationships, inventories, and orders across a vast network of retailers, ecommerce, and distributors. As a suite of informed applications and analytics built on top of aggregated channel inventory and point-of-sale (POS) data, IntegriChain provides customer operations, national accounts, and finance teams with a collaborative, agile, and mobile alternative to ERP and homegrown systems. By embedding big-data customer insights into daily business processes, IntegriChain helps control the high cost of product distribution while improving product availability, ensuring a higher level of revenue predictability and maximizing distribution investment. More than $200 billion in annual U.S. commerce and two billion transactions flow through the IntegriChain Cloud annually. IntegriChain is backed by Accel-KKR, a leading technology private equity firm. For more information, visit www.integrichain.com and our blog, and follow us on Twitter @IntegriChain and LinkedIn.
IntegriChain is a registered trademark of IntegriChain Incorporated. All other trademarks are property of their respective owners.
Contact Jennifer Guinan | Sage Strategic Marketing 610.410.8111 Jennifer@sagestrat.com
Save the date!
Webinars & Resources
See List
